Scholars Central

Conference abstract

Enabling tools for gene therapy viral vector development

Authors: Ana Sofia Coroadinha

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Virus-Based Biopharmaceuticals (VBBs) produced in animal cells such as oncolytic vectors, virus-like particle vaccines and gene transfer vectors are among the most promising bioproducts. Gene therapy viral vectors interest and investment has grown significantly leveraged by, the recent approvals of gene therapeutic products Glybera and Strimvelis and by the very encouraging results obtained with Chimeric Antigen Receptor (CAR)-T cells in cancer treatments. For the successful marketing of gene therapy, viral vectors enhanced and competitive manufacturing processes are required. On the other hand VBBs development can be cumbersome. The establishment of cell lines for virus production is an intensive and time consuming work. In addition, virus titration methods are laborious and often lack accuracy. In our research, we are developing novel enabling technologies that contribute for the progress in viral vector and cell line development. Different approaches can be used in cell line development. We have been using targeted integration and recently developed a high throughput cell line screening technology, the Single-Step Cloning Screening technology (SSCS). The SSCS merges cloning and screening by using split-GFP, a green fluorescent protein separated into 2 fragments which fluoresce upon transcomplementation. It can be used in cell line development, cell engineering as well as in vector engineering. We could obtain retroviral vector clones producing 1x108 infectious particles per mL and improved IP/TP ratios. To further expand SSCS approach to other virus and in order to quantify virus we are developing Visensors. The latter are cell based biosensors for label-free virus. Herein we will present and discuss these novel technologies which face the state of the art methodologies and how they can contribute for faster development of viral vectors for gene therapy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Stem Cell Research & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Stem Cell Research & Therapy
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Ana Sofia Coroadinha”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels